Cas:100-10-7 p-Dimethylaminobenzaldehyde manufacturer & supplier

We serve Chemical Name:p-Dimethylaminobenzaldehyde CAS:100-10-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

p-Dimethylaminobenzaldehyde

Chemical Name:p-Dimethylaminobenzaldehyde
CAS.NO:100-10-7
Synonyms:N,N-Dimethyl-p-aminobenzaldehyde;p-(N,N-Dimethylamino)benzaldehyde;p-N,N-Dimethylaminobenzaldehyde;Ehrlichs;p-dimethylaminobenzaldehyde;EINECS 202-819-0;EHRICH’S REAGENT;N,N-Dimethyl-4-aminobenzaldehyde;Para-Dimethylaminobenzaldehyde;p-Formyldimethylaniline;4-(Dimethylamino)benzaldehyde;HYDRAZINE-REAGENT;4-N,N-dimethylaminobenzaldehyde;MFCD00003381;p-DAB;Benzaldehyde, 4-(dimethylamino)-;reagensehrlichovo;EHRLICH’S REAGENT;ERLICH’S REAGENT;VHR DN1&1;p-(Dimethylamino)benzaldehyde
Molecular Formula:C9H11NO
Molecular Weight:149.190
HS Code:2912210000

Physical and Chemical Properties:
Melting point:72-75 °C(lit.)
Boiling point:266.5±23.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.596
PSA:20.31000
Exact Mass:149.084061
LogP:1.81

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2920 8/PG 2
Packing Group:I; II; III


Contact us for information like N,N-Dimethyl-p-aminobenzaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,p-(Dimethylamino)benzaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ehrlichs Use and application,reagensehrlichovo technical grade,usp/ep/jp grade.


Related News: RELATED: With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO dl-3-(3,5-dimethoxyphenyl)-2-methylpropionic acid ethylester manufacturers This scheme has a total outlay of Rs. 6,940 crore for the entire period. The applications under four different target segments were invited on November 30, 2020. Of the 215 applications, 36 products across the 4 target segments were granted. 2-((4-chloro-2-fluorophenyl)amino)-3,4-difluoro-N-(2-hydroxy-3-methoxypropoxy)benzamide suppliers Patients having Zynteglo treatment for beta thalassaemia also need conditioning treatment to clear out their bone marrow cells before receiving Zynteglo. Healthcare professionals should therefore explicitly inform patients receiving Zynteglo of the increased risk of blood cancers from medicines used in conditioning treatments. Benzoic acid, 2-[2-[(4,5-dimethyl-2-thiazolyl)amino]ethyl]-, methyl ester vendor & factory.